enGene
IPODetalimogene | Mainstreaming Non-Viral Gene Therapy for NMIBC
Public · Montreal, Canada · $17.9M raised
- Headquarters
- Montreal
- Employees
- 51–200
- Business Model
- B2B
- Website
- engene.com
- Total Funding
- $17.9M
- Last Round
- $11.5M Venture RoundJan 2018
- Rounds
- 3
- Type
- Public
About
enGene is a clinical-stage biotech pioneering non-viral gene therapy for non-muscle invasive bladder cancer and other mucosal tissue diseases.
Summary
enGene is a Biotech company based in Montreal, Canada. It has raised $17.9M in total across 3 rounds, most recently a $11.5M Venture Round round in Jan 2018. Investors include Adage Capital, Deerfield Management and Forbion Capital Partners.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Sign up to see all 6 rounds
Series A through Secondary Market — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/engene"><img src="https://indexed.vc/api/badge/company/engene" alt="enGene on Indexed.vc" width="260" height="76" /></a>